SHIP now forms part of the newly formed Grants, Innovation and Product Development Unit (GIPD). This incorporates the Self-Initiated Research Grants (SIR), Newton Fund Programmes, Grand Challenges South Africa, Strategic Research Initiatives, Platform & Specialist Scientific Services and Flagship Programmes.
There is a pressing need to develop new or improved drugs, diagnostics, vaccines, devices, prevention strategies and treatments to address South Africa’s major health problems
South Africa has the capability to do this but it requires strategic, multi-disciplinary and multi-institutional partnerships, facilitated by dedicated, milestone-driven funding and focused project management.
What does SHIP do?
Seek, manage and fund multi-disciplinary, multi-institutional product research, development and innovation projects from discovery to proof-of-concept
Enhance the capacity of South African science in the research and development of novel or improved drugs, vaccines and other biologicals, diagnostics and medical devices in the identified priority diseases
Facilitate, through partnerships with local universities, science councils and the private sector, the transfer of research outputs into improved health outcomes and/or social benefit
Along with its Technology Transfer unit, develop pathways to facilitate the seamless movement of new products and services from the laboratory to the marketplace.
SHIP is still seeking to fill gaps in our project pipeline that were not addressed in our First 2 RFA’s. We would welcome concept notes (2 pages max) in any of the topics listed.
2nd Floor Building A, MRC Medicina Campus, Francie van Zijl Drive, Parow Valley, Cape Town
Tel: 021 938 0351; Fax: 021 938 0385; Email: email@example.com